Lya Magdalena Moneva-Leniz, Servicio de Dermatología, Hospital Universitario Doctor Peset de Valencia, Valencia, España
Eva M. Sánchez-Martínez, Servicio de Dermatología, Hospital Universitario Doctor Peset de Valencia, Valencia, España
Héctor Gegundez-Hernández, Servicio de Dermatología, Hospital Universitario Doctor Peset de Valencia, Valencia, España
Sara Ayala-Martínez, Servicio de Anatomía Patológica, Hospital Universitario Doctor Peset de Valencia, Valencia, España
Amparo Fuertes-Prosper, Servicio de Dermatología, Hospital Universitario Doctor Peset de Valencia, Valencia, España
Almudena Mateu-Puchades, Servicio de Dermatología, Hospital Universitario Doctor Peset de Valencia, Valencia, España
We report the case of a 56-year-old woman with vesiculobullous eosinophilic cellulitis (EC) that relapsed after an asymptomatic period of 18 years without a recognizable trigger, which responded to leflunomide, after failure to treatment with hydroxychloroquine and methotrexate. EC is an infrequent entity that can be associated to hematological malignancies. Oral corticosteroids have proved to be the most effective treatment, but relapses are frequent after stopping them. Multiple corticoid- sparing agents have been used with diverse results. This is the first case report of EC with favorable response to leflunomide.
Keywords: Wells syndrome. Eosinophilic cellulitis. Leflunomide.